Navigation Links
Former Scientific Director at Genomics Institute of Novartis Research Foundation Named President of Cell Therapeutics Europe
Date:10/3/2008

with not successfully finalizing the proposed spin-off, the inability to successfully fund Ap(3)ana, competitive factors, challenges arising from doing business in Italy and the risk factors listed or described from time to time in CTI's filings with the Securities and Exchange Commission including, without limitation, CTI's most recent filings on Forms 10-K, 8-K, and 10-Q. Specifically, the risks and uncertainties that could affect CTI include risks associated with preclinical and clinical developments in the biopharmaceutical industry in general including, without limitation, the potential failure of a product to prove safe and effective for treatment of a specific condition, determinations by regulatory, patent and administrative governmental authorities, competitive factors, technological developments, costs of developing, producing and selling the product(s), and the risk factors listed or described from time to time in CTI's filings with the Securities and Exchange Commission including, without limitation, CTI's most recent filings on Forms 10-K, 8-K, and 10-Q. CTI continues to have substantial amount of debt outstanding and the quarterly interest expense associated with the debt is significant; CTI's operating expenses continue to exceed its net revenues and CTI will continue to need to raise capital to fund its operating expenses; as well as other risks listed or described from time to time in CTI's most recent filings with the SEC on Forms 10-K, 8-K and 10-Q. Except as may be required by law, CTI does not intend to update or alter its forward-looking statements whether as a result of new information, future events, or otherwise.

Sign up for email alerts and get RSS feeds at our Web site, http://www.CellTherapeutics.com/investors_news.htm.

Media Contact:

Dan Eramian

T: 206.272.4343

C: 206.854.1200

E:

SOURCE Cell Therapeutics, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Vermillion (Formerly Ciphergen) Announces $20.5 Million Private Placement of Common Stock
2. Former Banc of America Securities Analyst David Maris Comments on Decision by Biovail to Drop Its Claims Against Him; Denies That He is Cooperating With Biovail
3. David Barker, Former Illumina CSO, Joins GenVaults Scientific Advisory Board
4. Former Pfizer Director of Inflammation Molecular Sciences to Spearhead Velcura Therapeutics Inflammatory Disease Initiatives
5. Kendle Appoints Former MHRA Head of Biologics as Principal Regulatory Affairs Consultant
6. Seahorse Bioscience Appoints Former Molecular Devices Executive Dr. Joseph D. Keegan to Board of Directors
7. Former Patent Office Solicitor and Judge Joins Rothwell Figg
8. Leading DHA Expert and Former NIH Researcher, Dr. Norman Salem, Jr., to Join Martek as Chief Scientific Officer
9. Molecular Diagnostics Leader AdvanDx Taps Former Dako Executive Vice President to Lead Global Sales and Marketing Expansion
10. Former Manchester City Lord Mayor Has Hope Restored at New Beike Stem Cell Facility
11. John E. Leonard, Ph.D., Former Biogen Idec Antibody Development Executive, Joins the Scientific Advisory Board of Vaccinex, Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/21/2014)... 21, 2014 Mathematic studies at the Program ... and funded by the Jeffrey Epstein VI Foundation , ... be visually identified for elimination. These aggressive cells are the ... shows a topological map of what to look for when ... for while tumor cells can be extracted from biopsy, it,s ...
(Date:8/21/2014)... NJ (PRWEB) August 21, 2014 ... personal selling optimization technology and services for Life ... of “Grading Pharma’s Use of New Commercial Sales ... Measurement & Analytics. , The article examines some ... yield that are being tested in the pharmaceutical ...
(Date:8/21/2014)... On Wednesday of last week RENU 28, the ... molecules, became available for purchase in Australia and New Zealand, ... RENU 28 works is, if you think about the definition ... of cellular renewal within your body. If you think about ... of cellular renewal. What RENU 28 does is it works ...
(Date:8/20/2014)... in measuring vibrational motion of a single molecule with ... of a single molecule differs from the behaviour of ... at the University of California, Irvine, where post-doctoral researcher ... a visiting fellow under professor Vartkess A. Apkarian, whose ... lead by Professor Eric O. Potma. The results of ...
Breaking Biology Technology:Science Power Jeffrey Epstein and Harvard University Fund Project to Visually Stop Tumor Growth 2Pursuit's Peter Robinson Publishes "Grading Pharma's Use of New Commercial Sales Models" 2RENU 28 Skin Care Now Available in Australia and New Zealand 2Seeing a molecule breathe 2
... Advances in biotechnology and life science research coupled with broader range ... culture market. Growth is likely to be fueled by heightened interest ... of industrial biopharmaceuticals. , ... San Jose, CA (PRWEB) ...
... today the,submission of the response to the FDA ... Single Dose Containers). In an,Approvable Letter received on ... respect to chemistry, manufacturing, and controls (CMC)., ... response as a Class 2,resubmission, under which the ...
... Calif., Nov. 5 Telik, Inc.,(Nasdaq: TELK ) ... per share, for,the third quarter ended September 30, 2008, ... per share, for the comparable period in 2007. The,$8.0 ... to,corporate and municipal notes investments with an auction reset ...
Cached Biology Technology:Cell/Tissue Culture Supplies Market to Reach $4.97 Billion by 2012, According to New Report by Global Industry Analysts 2Cell/Tissue Culture Supplies Market to Reach $4.97 Billion by 2012, According to New Report by Global Industry Analysts 3SALVAT Announces Submission of Complete Response to FDA Approvable Letter for CETRAXAL(R) 2Telik Announces Financial Results for 2008 Third Quarter 2Telik Announces Financial Results for 2008 Third Quarter 3Telik Announces Financial Results for 2008 Third Quarter 4
(Date:8/20/2014)... Tennessee, Knoxville, research finds life can persist in a ... part of a team that examined waters and sediments ... sheet and found the extreme environment supports microbial ecosystems. ... Mikucki and her colleagues has implications for life in ... solar system. The findings are published in the current ...
(Date:8/20/2014)... -- Bay Area Lyme Foundation, which aims to make ... applauds new research published in an upcoming issue of ... Diseases . The findings show that ticks that ... the year, making the threat of Lyme disease year-round. ... of Public Health (CDPH) Vector-borne Disease Section and University ...
(Date:8/20/2014)... causes a burning spiciness that is irresistible to some, ... effect are using their findings to develop a new ... be caused by inflammation or other problems. They reported ... in clinical trials, in ACS, Journal of Medicinal ... decades ago, scientists had pegged a compound called capsaicin ...
Breaking Biology News(10 mins):University of Tennessee research uncovers subglacial life beneath Antarctic ice sheet 2Lyme disease risk is year-round in Northwest California, according to new study 2Lyme disease risk is year-round in Northwest California, according to new study 3
... pollination season approaches in Pennsylvania and the Northeast, scientists ... to the decline of the nation,s honeybees and other ... billion worth of crops in the United States. To ... has stepped up to support honeybee research and education. ...
... X-rays have been used for decades to take ... Department of Energys (DOE) Argonne National Laboratory and their ... take images of ultra-small structures buried in nanoparticles and ... cellular nuclei. Argonne scientists along with scientists from ...
... puzzle found in rocks half a billion years old. ... world are the Burgess Shales in the Canadian Rockies. Once ... suddenly became more complex and diverse the so-called Cambrian ... Normally, only hard parts of ancient animals became fossilised; the ...
Cached Biology News:Haagen-Dazs gift to support Penn State honeybee research 2Haagen-Dazs gift to support Penn State honeybee research 3Lensless camera uses X-rays to view nanoscale materials and biological specimens 2Lensless camera uses X-rays to view nanoscale materials and biological specimens 3
... anti-Cytohesin 2, Monoclonal Antibody, Unconjugated ... dependent dilution. ICC: Use at an assay dependent ... - 10 ug/ml, this concentration is determined using ... weight: 40 kDa. Not tested in other applications. ...
Recognizes TWIK-2. Does not cross react with any other known proteins....
Anti human PPAR gamma2 mouse monoclonal antibody...
200 μg per ml DNA in 10 SSPE, 2 Denhardt's...
Biology Products: